Gaba transporter SLC6A11 gene polymorphism associated with tardive dyskinesia

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nordic Journal of Psychiatry

• Publication date

  2014-01-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/08039488.2013.780260PMID 23795861
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No Association between PAWR Gene Polymorphisms and Tardive Dyskinesia in Schizophrenia Patients

  2012cited by this paper
• No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia Patients

  2011cited by this paper
• Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses

  2009cited by this paper
• A candidate gene study of tardive dyskinesia in the CATIE schizophrenia trial

  2009cited by this paper
• No Evidence for Association between Tyrosine Hydroxylase Gene Val81Met Polymorphism and Susceptibility to Tardive Dyskinesia in Schizophrenia

  2009cited by this paper
• Association study between glutathione S‐transferase GST‐M1, GST‐T1, and GST‐P1 polymorphisms and tardive dyskinesia

  2009cited by this paper
• Pathway-based association analysis of genome-wide screening data suggest that genes associated with the &ggr;-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia

  2008cited by this paper
• Val158Met Polymorphism in the Catechol-O-Methyltransferase (COMT) Gene Is Not Associated with Tardive Dyskinesia in Schizophrenia

  2008cited by this paper
• No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients.

  2008cited by this paper
• Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients.

  2008cited by this paper
• Odds ratio based multifactor-dimensionality reduction method for detecting gene-gene interactions

  2007cited by this paper
• No evidence for an association between G protein β3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia

  2007cited by this paper
• No Association between Dopamine D4 Receptor Gene –521 C/T Polymorphism and Tardive Dyskinesia in Schizophrenia

  2007cited by this paper
• The effect of reduction in cross‐validation intervals on the performance of multifactor dimensionality reduction

  2006cited by this paper
• Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains

  2005cited by this paper
• Power of multifactor dimensionality reduction for detecting gene‐gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity

  2003cited by this paper
• Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives.

  2003cited by this paper
• Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

  2000cited by this paper
• A Korean population study of the nine STR loci FGA, VWA, D3S1358, D18S51, D21S11, D8S1179, D7S820, D13S317 and D5S818

  2000cited by this paper
• Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia.

  1995cited by this paper
• Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.

  1990cited by this paper
• Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis

  1984cited by this paper
• Research diagnoses for tardive dyskinesia.

  1982cited by this paper
• Familial tardive dyskinesia.

  1981cited by this paper
• γ-Acetylenic GABA in Tardive Dyskinesia

  1980cited by this paper
• gamma-Acetylenic GABA in tardive dyskinesia.

  1980cited by this paper
• Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.

  1979cited by this paper
• The pathophysiologic basis of tardive dyskinesia.

  1977cited by this paper

• Investigation of the Mechanism of Action of the Mongolian Medicine Eerdun Wurile Basic Formula in the Treatment of Ischemic Stroke Through Transcriptomics and Metabolomics Integration

  2025cites this paper
• Recurrent gene flow between Neanderthals and modern humans over the past 200,000 years

  2024cites this paper
• Machine Learning and Pharmacogenomics at the Time of Precision Psychiatry

  2023cites this paper
• Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies

  2022cites this paper
• Association Study between Serotonin 1A Receptor Gene rs6295 Polymorphism and Tardive Dyskinesia in Patients with Schizophrenia

  2020cites this paper
• Candidate genes involved in the development of antipsychotic-induced tardive dyskinesia in patients with schizophrenia

  2020cites this paper
• Association between the IL10 rs1800896 Polymorphism and Tardive Dyskinesia in Schizophrenia

  2020cites this paper
• New findings in pharmacogenetics of schizophrenia

  2018cites this paper
• Future directions in tardive dyskinesia research.

  2018cites this paper
• Genetics of tardive dyskinesia: Promising leads and ways forward.

  2018cites this paper
• Classification of psychopathology: conceptual and historical background

  2018cites this paper
• Management of common adverse effects of antipsychotic medications

  2018cites this paper
• Genome wide study of tardive dyskinesia in schizophrenia

  2018cites this paper
• Association study between the neurexin‐1 gene and tardive dyskinesia

  2017cites this paper
• Pharmacogenomics in Asia: a systematic review on current trends and novel discoveries.

  2017cites this paper
• Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesia

  2016cites this paper
• The association between COMT Val158Met gene polymorphism and antipsychotic-induced tardive dyskinesia risk

  2016cites this paper
• Pharmacogenetics of tardive dyskinesia: an updated review of the literature.

  2016cites this paper
• Chapter 22 – Drug-Induced Movement Disorders in Children

  2016cites this paper
• Фармакогенетический подход к оценке риска развития индуцированных антипсихотиками экстрапирамидных нарушений

  2015cites this paper
• [Pharmacogenetic-based risk assessment of antipsychotic-induced extrapyramidal symptoms].

  2015cites this paper
• Коррекция распространенных побочных эффектов антипсихотических препаратов

  year unknowncites this paper